
|Articles|September 1, 2001
Supplements and Featured Publications
- Depression and Generalized Anxiety Disorder: Managed Care Considerations
- Volume 7
- Issue 11 Suppl
Recent Perspectives on the Diagnosis and Treatment of Generalized Anxiety Disorder
Author(s)Philip T. Ninan, MD
Advertisement
Articles in this issue
over 24 years ago
Participating Facultyover 24 years ago
Introductionover 24 years ago
The Pharmacoeconomics of Venlafaxine in DepressionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib
5














































